PB0364 Glycoprotein VI-Targeted Antiplatelet Therapy with Glenzocimab is Safe in Patients Exposed to Current Antithrombotic and Fibrinolytic Drugs

Autor: Jandrot-Perrus, M., Pottecher, J., Toledano, E., Commenducci, A., Meilhoc, A., Gharakhanian, S., Avenard, G., Pletan, Y., Binay, S., Mazighi, M.
Zdroj: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Databáze: ScienceDirect
Externí odkaz: